← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2002First marketed drug
May 21, 2004First NDA
Jan 17, 2013Last known activity
Dec 31, 2025
Timeline
1980s
- Jan 1, 1983
Octapharma— Founded
2000s
- May 21, 2004
immune globulin (human)— NDA Secondary Org
2010s
- Jan 17, 2013
blood plasma— NDA Organization
- Oct 8, 2015
Glycotope GmbH— Acquired
Drugs by trial phase (24 distinct, 72 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (1 own, 6 via acquisition)
Phase 1 (0 own, 2 via acquisition)
Indications
Studied for
- Afibrinogenemia
- Agammaglobulinemia
- alpha 1-Antitrypsin Deficiency
- Alzheimer Disease
- Aneurysm
- Antithrombin III Deficiency
- Aortic Aneurysm
- Aortic Aneurysm, Thoracic
- Dermatomyositis
- Disease Progression
- Encephalitis
- Hemophilia A
- Hemorrhage
- Immunologic Deficiency Syndromes
- Infections
- Inflammation
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Liver Diseases
- Peripheral Nervous System Diseases
- Polyradiculoneuropathy
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
- Pre-Eclampsia
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Purpura, Thrombotic Thrombocytopenic
- Shock
- Shock, Septic
- Streptococcal Infections
- Syndrome
- Thrombocytopenia
- von Willebrand Diseases
Marketed drugs (7)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT07220915Lead sponsorPhase 3Dec 31, 2025
- NCT06096116Lead sponsorPhase 3Jun 30, 2024
- NCT06361537Lead sponsorPhase 3Apr 30, 2024
- NCT05935358Study directorPhase 4Oct 31, 2023
- NCT05935358Lead sponsorPhase 4Oct 31, 2023
- NCT05936580Lead sponsorPhase 4Oct 31, 2023
- NCT04929236Lead sponsorPhase 3Dec 31, 2021
- NCT04918173Lead sponsorPhase 3Oct 31, 2021
- NCT04867837Lead sponsorPhase 3Sep 1, 2021
- NCT04953884Lead sponsorPhase 3Jul 28, 2021
- NCT04640142Lead sponsorPhase 3Jun 30, 2021
- NCT04534751CollaboratorPhase 4Apr 1, 2021
- NCT04508530Lead sponsorPhase 3Jan 1, 2021
- NCT04502030Lead sponsorPhase 3Oct 5, 2020
- NCT04376762CollaboratorPhase 4Sep 1, 2020
Details
- Founded
- Lachen, CH Jan 1, 1983
- First NDA
- Jan 17, 2013
- Last known activity
- Dec 31, 2025